Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Pathway Focus: GLP-1 + GIP What is Retatrutide
Nausea, reduced appetite, early fullness, constipation, diarrhea, bloating, burping, reflux, and abdominal discomfort are frequently reported by patients starting GLP-1 therapy
& Cecchelli, R
Patients who microdose successfully typically spend 812 weeks in the titration phase, reaching therapeutic doses between 0.52.4 mg weekly depending on their response profile
Overuse: Excessive physical activity or repetitive motions cause muscle and joint pain
Retatrutide has passed the early stages and is now in the final stretch
US$ 27.09
US$ 26.83
US$ 28.32
US$ 27.41
